United Kingdom
# |
Name |
Free Cash Flow Per Share |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 4.20
|
Dec. 31, 2023 | USD 139.13 | 1.09% |
|
United Kingdom |
|
2 |
USD 0.74
|
Dec. 31, 2023 | USD 49.95 | -1.36% |
|
United Kingdom |
|
3 |
USD 0.02
|
Dec. 31, 2023 | USD 0.23 | -1.64% |
|
United Kingdom |
|
4 |
USD -0.00
|
Dec. 31, 2023 | USD 0.32 | 1.02% |
|
United Kingdom |
|
5 |
USD -0.01
|
June 30, 2024 | USD 0.01 | -16.48% |
|
United Kingdom |
|
6 |
USD -0.02
|
Dec. 31, 2023 | USD 0.16 | 0.22% |
|
United Kingdom |
|
7 |
USD -0.02
|
Dec. 31, 2023 | USD 0.03 | -13.02% |
|
United Kingdom |
|
8 |
USD -0.02
|
April 30, 2024 | USD 0.11 | -2.49% |
|
United Kingdom |
|
9 |
USD -0.03
|
Dec. 31, 2023 | USD 3.01 | 2.73% |
|
United Kingdom |
|
10 |
USD -0.04
|
Sept. 30, 2023 | USD 0.15 | -5.79% |
|
United Kingdom |
|
11 |
USD -0.04
|
Dec. 31, 2023 | USD 0.05 | 0.22% |
|
United Kingdom |
|
12 |
USD -0.05
|
Dec. 31, 2023 | USD 32.88 | 0.83% |
|
United Kingdom |
|
13 |
USD -0.05
|
Dec. 31, 2023 | USD 0.03 | 15.64% |
|
United Kingdom |
|
14 |
USD -0.06
|
June 30, 2024 | USD 0.24 | 0.22% |
|
United Kingdom |
|
15 |
USD -0.07
|
Dec. 31, 2023 | USD 0.04 | 18.86% |
|
United Kingdom |
|
16 |
USD -0.08
|
Dec. 31, 2023 | USD 0.59 | 3.49% |
|
United Kingdom |
|
17 |
USD -0.09
|
Dec. 31, 2023 | USD 0.22 | -0.34% |
|
United Kingdom |
|
18 |
USD -0.10
|
Dec. 31, 2023 | USD 0.05 | 0.22% |
|
United Kingdom |
|
19 |
USD -0.12
|
Aug. 31, 2023 | USD 0.11 | -15.01% |
|
United Kingdom |
|
20 |
USD -0.13
|
Dec. 31, 2023 | USD 0.26 | 0.22% |
|
United Kingdom |
|
21 |
USD -0.18
|
Dec. 31, 2023 | USD 0.57 | 0.22% |
|
United Kingdom |
|
22 |
USD -0.25
|
Dec. 31, 2023 | USD 0.68 | -3.32% |
|
United Kingdom |
|
23 |
USD -0.32
|
March 31, 2024 | USD 1.06 | -3.64% |
|
United Kingdom |
|
24 |
USD -0.63
|
Dec. 31, 2023 | USD 57.30 | 0.10% |
|
United Kingdom |
|
25 |
USD -0.90
|
Dec. 31, 2023 | USD 2.21 | 0.46% |
|
United Kingdom |
|
26 |
USD -0.98
|
March 31, 2024 | USD 11.13 | -2.11% |
|
United Kingdom |
|
27 |
USD -1.24
|
Dec. 31, 2023 | USD 1.13 | 0.89% |
|
United Kingdom |
|
28 |
USD -1.35
|
Dec. 31, 2023 | USD 5.33 | 1.52% |
|
United Kingdom |
|
29 |
USD -1.67
|
Dec. 31, 2023 | USD 16.92 | 0.06% |
|
United Kingdom |
|
30 |
USD -1.71
|
Dec. 31, 2023 | USD 1.16 | -5.69% |
|
United Kingdom |
|
31 |
USD -1.79
|
Dec. 31, 2023 | USD 13.39 | 4.86% |
|
United Kingdom |
|
32 |
USD -1.91
|
Dec. 31, 2023 | USD 4.31 | 3.36% |
|
United Kingdom |
|
33 |
USD -3.36
|
Dec. 31, 2023 | USD 1.09 | -19.26% |
|
United Kingdom |
The Clinical Trials company in United Kingdom with the highest Free Cash Flow Per Share is AstraZeneca PLC (LSE: AZN.L) at USD 4.20.
The Clinical Trials company in United Kingdom with the lowest Free Cash Flow Per Share is Akari Therapeutics, Plc (NasdaqCM: AKTX) at USD -3.36.
The top 10 Clinical Trials companies in United Kingdom by Free Cash Flow Per Share are AstraZeneca PLC, LivaNova PLC, hVIVO plc, EKF Diagnostics Holdings plc, Physiomics Plc, Intelligent Ultrasound Group plc, Roquefort Therapeutics plc, Scancell Holdings plc, Mereo BioPharma Group plc and IXICO plc.
The bottom 10 Clinical Trials companies in United Kingdom by Free Cash Flow Per Share are Akari Therapeutics, Plc, COMPASS Pathways plc, Bicycle Therapeutics plc, Aptorum Group Limited, Centessa Pharmaceuticals plc, Silence Therapeutics plc, Achilles Therapeutics plc, Roivant Sciences Ltd., Autolus Therapeutics plc and Verona Pharma plc.